Navigation Links
Rancho BioSciences Will Present the Accelerated Cure Project Multiple Sclerosis Data Curation White Paper at the tranSMART Fall Developers Meeting, Paris, November 5-7
Date:11/5/2013

San Diego, California (PRWEB) November 05, 2013

Rancho BioSciences, the global scientific data consulting company, announced today that they will be presenting their Multiple Sclerosis data curation project for the Accerlerated Cure Project (ACP) at the tranSMART Fall Developers Meeting hosted by Sanofi in Chilly-Mazarin, Paris November 5-7, 2013. Dr. Stephen Wicks of Rancho BioSciences, who has been on site at ACP, will be discussing the types of data that he had to curate, from extensive clinical information to expression and GWAS data. This information has then been uploaded into a public-domain platform, tranSMART for further analysis. A white paper covering this project will be available on Rancho BioSciences web site.

“I will share the data curation process, issues and how we found solutions to prepare the data for analysis”, said Dr. Wicks. “The end point was to load clinical, expression, and other biomarker data in tranSMART that will then be used for analysis and the development of predictive disease models for Multiple Sclerosis. This will allow researchers to classify MS patients better and more accurately, ultimately finding the best treatment or cure faster for each individual patient.”

About Rancho BioSciences
Rancho BioSciences is a fee-for-service data-curation company leveraging open-source tools and public-domain data. Our customers include Pharma, Institutes, and Academics.

We have a team of experienced Ph.D. and M.D. scientists around the world that deliver high quality work based on their expertise and domain knowledge in biology, diseases, and clinical data. Rancho BioSciences is flexible and cost effective, providing on site and off site curators.

Rancho BioSciences also has expertise in databases and hosts or installs tranSMART for their customers.

Our goal is to help the life-science community build better tools and take advantage of a wealth of scientific data by supporting and developing open source platforms.

For more information about Rancho BioSciences, please visit us online at ranchobiosciences.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11300323.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rancho BioSciences will present the tranSMART open source platform at TM Forum’s Digital Disruption 2013, Oct 28-31, San Jose
2. Rancho BioSciences Partners with OmicSoft for Manual Data Curation
3. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
4. Microvi and Aquatech Break Ground on Large Demonstration System at Aerojet Site in Rancho Cordova, CA
5. Regado Biosciences, Inc. to Provide Third Quarter 2013 Financial Results
6. Neurocrine Biosciences Reports Third Quarter 2013 Results
7. Proove Biosciences Will Be Exhibiting At The 2013 Common Sense Pain Management Conference
8. Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree
9. Sangamo BioSciences Reports Third Quarter 2013 Financial Results
10. Jeeven BioSciences, Inc. Announces the Release of Its Neuro-XTM Serum-Free and Xeno-Free Tissue Culture Media
11. Castle Biosciences Launches Tissue Repository for Eye Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):